Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JS-K induces autophagy-dependent ferroptosis in bladder cancer: a multimodal mechanistic and translational study.

Precision clinical medicine·2026
Same author

Performance enhancement and environmental assessment of ultra-fine tailings mortars using waste-derived binders activated by alkali-sulfate.

Environmental research·2026
Same author

Mitochondria-derived vesicles serve as reactors in response to stress in cardiomyocytes.

Cell communication and signaling : CCS·2025
Same author

JS-K enhances renal cell carcinoma radiosensitivity through the Wnt/β-catenin signaling pathway and inhibits DNA damage repair.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis.

Scientific reports·2025
Same author

PAD2 disturbs cardiomyocyte calcium homeostasis by citrullinating SERCA2a protein in hemorrhagic shock induced arrhythmia.

The journal of trauma and acute care surgery·2025
Same journal

Identification of chondroitin polymerizing factor as a biomarker for predicting immunotherapy response in breast cancer: a bioinformatics analysis of tumor microenvironment.

Translational cancer research·2026
Same journal

Neuro-glioma activity-dependent growth mechanisms: an actionable circuit from NLGN3-ADAM10 to AMPA synapses.

Translational cancer research·2026
Same journal

Association of serum vitamins and carotenoids with breast cancer status among adult women in NHANES 2017-2018: a cross-sectional study.

Translational cancer research·2026
Same journal

Development and validation of prognostic nomograms for patients with cervical cancer and liver metastasis: a SEER-based study.

Translational cancer research·2026
Same journal

Epcoritamab plus gemcitabine and oxaliplatin in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: how should this regimen be positioned in current treatment algorithms?

Translational cancer research·2026
Same journal

Circadian-immune-related gene signature for lung squamous cell carcinoma: machine learning and multi-omics analysis.

Translational cancer research·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K

Decrease in radiation therapy rates in patients with stage I seminoma: a population-based study.

Shi Jia1, Jingping Qiu2

  • 17th General Surgery Unit, Shengjing Hospital of China Medical University, Shenyang, China.

Translational Cancer Research
|February 4, 2022
PubMed
Summary
This summary is machine-generated.

Radiotherapy use for stage I seminoma has significantly declined over 40 years, with active surveillance and chemotherapy now preferred. Overall survival rates remain stable, indicating a shift in essential treatment strategies for this cancer.

Keywords:
Seminomabeam radiationtreatmenttrends

More Related Videos

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

7.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K

Related Experiment Videos

Last Updated: Oct 4, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

7.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K

Area of Science:

  • Oncology
  • Urologic Oncology
  • Cancer Treatment Trends

Background:

  • Radiotherapy was historically the standard adjuvant treatment for stage I seminoma post-orchidectomy.
  • Active surveillance and carboplatin chemotherapy have emerged as viable alternative management strategies.
  • The transition in treatment paradigms for stage I seminoma requires comprehensive analysis.

Purpose of the Study:

  • To analyze the 40-year trend in the utilization of radiotherapy for stage I seminoma in the United States.
  • To investigate shifts in treatment modalities, including radiotherapy, chemotherapy, and surveillance.
  • To examine patient survival outcomes in relation to evolving treatment strategies.

Main Methods:

  • Utilized the Surveillance, Epidemiology, and End Results (SEER) database (1975-2015) to identify 21,976 men with localized testis seminoma.
  • Analyzed the annual rates of radiotherapy, chemotherapy, and surveillance based on diagnosis year.
  • Correlated patient characteristics with radiotherapy avoidance and assessed overall survival trends.

Main Results:

  • The rate of radiotherapy for stage I seminoma decreased from 52.9% (1975-2015) to 5.3% in 2015.
  • Younger (under 34) and married patients were more likely to avoid radiotherapy in the 21st century.
  • Overall survival rates showed no statistical difference between 2008-2015 and 1975-1999, despite a dip in 2000-2007.

Conclusions:

  • The role of radiotherapy in stage I seminoma management has fundamentally shifted over the past four decades.
  • Radiotherapy is no longer considered an essential treatment in contemporary clinical practice for this condition.
  • Current trends favor less invasive strategies like surveillance and chemotherapy, maintaining comparable survival outcomes.